Trials / Unknown
UnknownNCT04957927
Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Usama Azhar · Academic / Other
- Sex
- All
- Age
- 2 Years – 5 Years
- Healthy volunteers
- Not accepted
Summary
To determine the Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age.
Detailed description
Our study will compare the Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age as in our population compliance with oral medication is better among patients, and is socially and culturally more acceptable.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age | Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age |
Timeline
- Start date
- 2020-12-12
- Primary completion
- 2021-09-12
- Completion
- 2021-12-12
- First posted
- 2021-07-12
- Last updated
- 2021-07-12
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT04957927. Inclusion in this directory is not an endorsement.